Results 91 to 100 of about 179,020 (284)
We have evaluated interinstitutional variation to verify the generalization and standardization of gastric cancer surgery from a supplementary analysis of the randomized phase III trial JCOG1001. Although there was some degree of interinstitutional variation in short‐ and long‐term outcomes after standard gastric surgery, we found no correlation ...
Motohiro Hirao +14 more
wiley +1 more source
Fusobacterium nucleatum contributes to the progression of ESCC by inducing NF‐κB–mediated inflammatory signaling in tumor cells and promoting CAFs activation. Its presence may facilitate immune exclusion and tumor invasion through stromal remodeling. Furthermore, F.
Takashi Ofuchi +9 more
wiley +1 more source
Overview of health care delivery and policy research in hepatology and liver transplantation [PDF]
Jayant A. Talwalkar
openalex +1 more source
The Need for Integrating Addiction Medicine and Hepatology [PDF]
Lorenzo Leggio, M. Katherine Jung
openalex +1 more source
This review critically reassesses our prior hypothesis and proposes a revised anatomical model of the fusion fascia that is broadly applicable to GI cancer surgeries grounded in the principles of mesenteric resection. Our synthesis suggests that the fusion fascia is neither a dense connective tissue membrane nor a remnant of mesothelial fusion, but ...
Hisashi Shinohara +9 more
wiley +1 more source
Application of artificial intelligence in hepatology: Minireview
Ryota Masuzaki +6 more
openalex +1 more source
Leveraging telemedicine in gastroenterology and hepatology: a narrative review [PDF]
Vahagn Aldzhyan +2 more
openalex +1 more source
ABSTRACT Over the past three decades, we have mentored a generation of young Japanese surgeons, guiding them to become internationally recognized surgeon‐scientists. Through a unique collaboration between Japanese academic institutions and our laboratories at AntiCancer Inc.
Robert M. Hoffman +2 more
wiley +1 more source
Total Neoadjuvant Therapy for Rectal Cancer: Why Japan Says “Not Yet”
ABSTRACT Total neoadjuvant therapy (TNT) has rapidly gained global acceptance as a standard treatment for locally advanced rectal cancer (LARC). Supported by multiple phase III trials, TNT improves pathological complete response (pCR) rates, enhances systemic control, and expands opportunities for non‐operative management (NOM).
Kay Uehara +4 more
wiley +1 more source

